10 Best Healthcare Stocks For Long-Term Investment

7. Lantheus Holdings, Inc. (NASDAQ:LNTH)

Number of Hedge Fund Holders: 39 

Lantheus Holdings, Inc. (NASDAQ:LNTH) is a radiopharmaceutical company specializing in diagnostic and therapeutic products for cardiology, oncology, and neurology. It develops advanced imaging agents and AI solutions to aid disease diagnosis and treatment. The company’s key products include PYLARIFY, a PET imaging agent for prostate cancer, and DEFINITY, an ultrasound contrast agent for cardiac imaging.

Lantheus Holdings, Inc. (NASDAQ:LNTH) is a top healthcare stock for long-term investment, backed by its strong market position in radiopharmaceuticals and impressive financial performance. In 2024, the company achieved significant revenue growth, reinforcing its market leadership.

For Q4 2024, Lantheus Holdings, Inc. (NASDAQ:LNTH) reported $391.1 million in revenue, a 10.5% year-over-year increase, while full-year revenue reached $1.53 billion, up 18.3%. PYLARIFY, its flagship PET imaging agent, surpassed $1 billion in net sales, growing 24.3% annually. DEFINITY, another key product, generated $317.8 million in revenue for the year, reflecting a 13.6% increase. Lantheus is among the best healthcare stocks with consistent growth.

The company maintained a strong 68% gross profit margin and generated $493.1 million in free cash flow in 2024. Looking ahead, Lantheus Holdings, Inc. (NASDAQ:LNTH) is expanding its portfolio with strategic acquisitions of Life Molecular Imaging and Evergreen Theragnostics, expected to close in H2 2025. These acquisitions aim to enhance its radiopharmaceutical capabilities, positioning the corporation for sustained double-digit revenue growth from 2026 onward.